Twist Bioscience

The Amazon of DNA

South San Francisco, California, United States

Twist Bioscience is a public biotechnology company manufacturing synthetic DNA and DNA products using a proprietary semiconductor-based process. Their innovative method allows for faster and more affordable production of high-quality synthetic DNA, used in products like synthetic genes and antibody libraries for drug discovery.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Twist Bioscience on @MedStartr Today Twist Bioscience is a public biotechnology company manufacturing synthetic DNA and DNA products using a proprietary semiconductor-based process. Their innovative method allows for faster and more affordable production of high-quality synthetic DNA, used in products like synthetic genes and antibody libraries for drug discovery. #CancerResearch #InfectiousDiseases #DrugDiscoveryBiologics #RareDiseases #MentalBehavioralHealth #DrugDiscoveryDevelopment #MedMo #MedStartrVentures

https://www.medstartr.ai/s/5zk7vVzMI24

Get Involved in Twist Bioscience

How We Help

Problem Statement

Twist Bioscience addresses the limitations of traditional DNA synthesis regarding throughput, cost, and scalability, which previously hindered the industrialization and broader application of engineered biology. Their platform overcomes these challenges to make synthetic DNA production faster, more affordable, and at an industrial scale.

Core Technology

proprietary semiconductor-based synthetic DNA manufacturing process, writing DNA on a silicon chip

Key Differentiators

faster and more affordable manufacturing of high-quality synthetic DNA

Clinical Focus

Cancer Research (detection, diagnostics, MRD testing, liquid biopsy, tumor profiling, hereditary oncology), Infectious Diseases (detecting and surveilling novel viral pathogens, SARS-CoV-2, monkeypox, universal flu vaccines), Drug Discovery & Biologics (antibody discovery and optimization for autoimmune, metabolic, and neurological diseases), Rare Diseases (whole exome analysis and focused rare disease-related sequences).

Target Customers

A wide range of industries, including synthetic biology, biopharma (drug discovery, biologics), and NGS tools customers (for cancer research, infectious diseases, rare diseases).

Product Stage

Mature

Company Info

Business Model: Operates a digital-to-biological manufacturing model, providing synthetic DNA-based products and services. Business segments include Synthetic Biology, NGS Tools, and Biopharma Services. Aims to be a foundational B2B provider of synthetic DNA, often described as the 'Amazon of DNA.'
Founded: 2011
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now
Website: www.twistbioscience.com/

Disease Areas

Cancer Research Infectious Diseases Drug Discovery & Biologics Rare Diseases Mental Health

Technologies

Synthetic DNANext-Generation Sequencing (NGS) PreparationAntibody LibrariesDNA SynthesisSynthetic BiologySilicon-Based TechnologyHigh-Throughput ProductionNext-Generation Sequencing Tools

Clinical & IP

🛡️

IP Protection

Strong patent portfolio.

🌐Website

MedStartr Engagement Score

Too Big!

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Twist Bioscience?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.